Anamnestic broadly reactive antibodies induced by H7N9 virus more efficiently bind to seasonal H3N2 strains

References

• WHO. Influenza (seasonal). [ accessed 2022 March 25]. https://www.who.int/en/news-room/fact-sheets/detail/influenza-seasonal
   Google Scholar
• Sautto GA, Kirchenbaum GA, Ross TM. Towards a universal influenza vaccine: different approaches for one goal. Virol J. 2018;15(1):1. doi:10.1186/s12985-017-0918-y.
   PubMedGoogle Scholar
• Tewawong N, Prachayangprecha S, Vichiwattana P, Korkong S, Klinfueng S, Vongpunsawad S, Thongmee T, Theamboonlers A, Poovorawan Y, Krammer F. Assessing antigenic drift of seasonal influenza A(H3N2) and A(H1N1)pdm09 viruses. PLoS One. 2015;10(10):e0139958. doi:10.1371/journal.pone.0139958.
   PubMed Web of Science ®Google Scholar
• Bedford T, Riley S, Barr IG, Broor S, Chadha M, Cox NJ, Daniels RS, Gunasekaran CP, Hurt AC, Kelso A, et al. Global circulation patterns of seasonal influenza viruses vary with antigenic drift. Nature. 2015;523(7559):217–11. doi:10.1038/nature14460.
   PubMed Web of Science ®Google Scholar
• Allen JD, Ross TM. H3N2 influenza viruses in humans: viral mechanisms, evolution, and evaluation. Hum Vaccin Immunother. 2018;14(8):184047. doi:10.1080/21645515.2018.1462639.
   Web of Science ®Google Scholar
• Hinojosa M, Shepard SS, Chung JR, King JP, McLean HQ, Flannery B, Belongia EA, Levine MZ. Impact of immune priming, vaccination, and infection on influenza A(H3N2) antibody landscapes in children. J Infect Dis. 2021;224(3):469–80. doi:10.1093/infdis/jiaa665.
   PubMed Web of Science ®Google Scholar
• Chambers BS, Parkhouse K, Ross TM, Alby K, Hensley SE. Identification of hemagglutinin residues responsible for H3N2 antigenic drift during the 2014–2015 influenza season. Cell Rep. 2015;12(1):1–6. doi:10.1016/j.celrep.2015.06.005.
   PubMed Web of Science ®Google Scholar
• Zimmerman RK, Nowalk MP, Chung J, Jackson ML, Jackson LA, Petrie JG, Monto AS, McLean HQ, Belongia EA, Gaglani M, et al. 2014–2015 influenza vaccine effectiveness in the United States by vaccine type. Clin Infect Dis. 2016;63(12):1564–73. doi:10.1093/cid/ciw635.
   PubMed Web of Science ®Google Scholar
• Neu KE, Henry Dunand CJ, Wilson PC. Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease? Curr Opin Immunol. 2016;42:48–55. doi:10.1016/j.coi.2016.05.012.
   PubMed Web of Science ®Google Scholar
• Fu Y, Zhang Z, Sheehan J, Avnir Y, Ridenour C, Sachnik T, Sun J, Hossain MJ, Chen LM, Zhu Q, et al. A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve. Nat Commun. 2016;7:12780. doi:10.1038/ncomms12780.
   PubMed Web of Science ®Google Scholar
• Christensen SR, Toulmin SA, Griesman T, Lamerato LE, Petrie JG, Martin ET, Monto AS, Hensley SE, Heise MT. Assessing the protective potential of H1N1 influenza virus hemagglutinin head and stalk antibodies in humans. J Virol. 2019;93(8): e02134-18. doi:10.1128/JVI.02134–18.
   PubMed Web of Science ®Google Scholar
• Dhar N, Kwatra G, Nunes MC, Cutland C, Izu A, Nachbagauer R, Krammer F, Madhi SA. Hemagglutinin stalk antibody responses following trivalent inactivated influenza vaccine immunization of pregnant women and association with protection from influenza virus illness. Clin Infect Dis. 2020;71(4):1072–79. doi:10.1093/cid/ciz927.
   PubMed Web of Science ®Google Scholar
• Ohshima N, Iba Y, Kubota-Koketsu R, Asano Y, Okuno Y, Kurosawa Y. Naturally occurring antibodies in humans can neutralize a variety of influenza virus strains, including H3, H1, H2, and H5. J Virol. 2011;85(21):11048–57. doi:10.1128/JVI.05397-11.
   PubMed Web of Science ®Google Scholar
• Pan Y, Sasaki T, Kubota-Koketsu R, Inoue Y, Yasugi M, Yamashita A, Ramadhany R, Arai Y, Du A, Boonsathorn N, et al. Human monoclonal antibodies derived from a patient infected with 2009 pandemic influenza a virus broadly cross-neutralize group 1 influenza viruses. Biochem Biophys Res Commun. 2014;450(1):42–48. doi:10.1016/j.bbrc.2014.05.060.
   PubMed Web of Science ®Google Scholar
• Krammer F, Margine I, Hai R, Flood A, Hirsh A, Tsvetnitsky V, Chen D, Palese P. H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge. J Virol. 2014;88(4):2340–43. doi:10.1128/JVI.03183-13.
   PubMed Web of Science ®Google Scholar
• Tan GS, Lee PS, Hoffman RM, Mazel-Sanchez B, Krammer F, Leon PE, Ward AB, Wilson IA, Palese P, Dermody TS. Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza a virus hemagglutinin. J Virol. 2014;88(23):13580–92. doi:10.1128/JVI.02289-14.
   PubMed Web of Science ®Google Scholar
• Estrada LD, Schultz-Cherry S. Development of a universal influenza vaccine. J Immunol. 2019;202(2):392–98. doi:10.4049/jimmunol.1801054.
   PubMed Web of Science ®Google Scholar
• Gostic KM, Ambrose M, Worobey M, Lloyd-Smith JO. Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting. Sci. 2016;354(6313):722–26. doi:10.1126/science.aag1322.
   PubMed Web of Science ®Google Scholar
• Francis T. On the doctrine of original antigenic sin. Proc Am Philos Soc. 1960;104:572–78.
   Google Scholar
• Lessler J, Riley S, Read JM, Wang S, Zhu H, Smith GJ, Guan Y, Jiang CQ, Cummings DA, Basler CF. Evidence for antigenic seniority in influenza a (H3N2) antibody responses in southern China. PLoS Pathog. 2012;8(7):e1002802. doi:10.1371/journal.ppat.1002802.
   PubMed Web of Science ®Google Scholar
• Fonville JM, Wilks SH, James SL, Fox A, Ventresca M, Aban M, Xue L, Jones TC, Le NMH, Pham QT, et al. Antibody landscapes after influenza virus infection or vaccination. Sci. 2014;346(6212):996–1000. doi:10.1126/science.1256427.
   PubMed Web of Science ®Google Scholar
• Miller MS, Gardner TJ, Krammer F, Aguado LC, Tortorella D, Basler CF, Palese P. Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis. Sci Transl Med. 2013;5(198):198ra107. doi:10.1126/scitranslmed.3006637.
   PubMed Web of Science ®Google Scholar
• Li Y, Myers JL, Bostick DL, Sullivan CB, Madara J, Linderman SL, Liu Q, Carter DM, Wrammert J, Esposito S, et al. Immune history shapes specificity of pandemic H1N1 influenza antibody responses. J Exp Med. 2013;210(8):1493–500. doi:10.1084/jem.20130212.
   PubMed Web of Science ®Google Scholar
• Worobey M, Plotkin S, Hensley SE. Influenza vaccines delivered in early childhood could turn antigenic sin into antigenic blessings. Cold Spring Harb Perspect Med. 2020;10(10):a038471. doi:10.1101/cshperspect.a038471.
   PubMed Web of Science ®Google Scholar
• Arevalo CP, Le Sage V, Bolton MJ, Eilola T, Jones JE, Kormuth KA, Nturibi E, Balmaseda A, Gordon A, Lakdawala SS, et al. Original antigenic sin priming of influenza virus hemagglutinin stalk antibodies. Proc Natl Acad Sci U S A. 2020;117(29):17221–27. doi:10.1073/pnas.1920321117.
   PubMed Web of Science ®Google Scholar
• Huang J, Hilchey SP, Wang J, Gerigan J, Zand MS. IL-15 enhances cross-reactive antibody recall responses to seasonal H3 influenza viruses in vitro. F1000res. 2017;6(2015). doi:10.12688/f1000research.12999.1.
   Google Scholar
• Wang J, Hilchey SP, Hyrien O, Huertas N, Perry S, Ramanunninair M, Bucher D, Zand MS, Krammer F. Multi-dimensional measurement of antibody-mediated heterosubtypic immunity to influenza. PLoS One. 2015;10(6):e0129858. doi:10.1371/journal.pone.0129858.
   PubMed Web of Science ®Google Scholar
• Sasaki S, Jaimes MC, Holmes TH, Dekker CL, Mahmood K, Kemble GW, Arvin AM, Greenberg HB. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol. 2007;81(1):215–28. doi:10.1128/JVI.01957-06.
   PubMed Web of Science ®Google Scholar
• Moody MA, Zhang R, Walter EB, Woods CW, Ginsburg GS, McClain MT, Denny TN, Chen X, Munshaw S, Marshall DJ, et al. H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination. PLoS One. 2011;6(10):e25797. doi:10.1371/journal.pone.0025797.
   PubMed Web of Science ®Google Scholar
• Wang J, Li D, Perry S, Hilchey SP, Wiltse A, Treanor JJ, Sangster MY, Zand MS, Rappuoli R. Broadly reactive IgG responses to heterologous H5 prime-boost influenza vaccination are shaped by antigenic relatedness to priming strains. mBio. 2021;12(4):e0044921. doi:10.1128/mBio.00449-21.
   PubMed Web of Science ®Google Scholar
• Qin L, Wang D, Li D, Zhao Y, Peng Y, Wellington D, Dai Y, Sun H, Sun J, Liu G, et al. High level antibody response to pandemic influenza H1N1/09 virus is associated with interferon-induced transmembrane protein-3 rs12252-CC in young adults. Front Cell Infect Microbiol. 2018;8:134. doi:10.3389/fcimb.2018.00134.
   PubMed Web of Science ®Google Scholar
• Islam S, Mohn KG, Krammer F, Sanne M, Bredholt G, Jul-Larsen Å, Tete SM, Zhou F, Brokstad KA, Cox RJ. Influenza a haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination. Vaccine. 2017;35(42):5666–73. doi:10.1016/j.vaccine.2017.08.044.
   PubMed Web of Science ®Google Scholar
• Tesini BL, Kanagaiah P, Wang J, Hahn M, Halliley JL, Chaves FA, Nguyen PQT, Nogales A, DeDiego ML, Anderson CS, et al. Broad hemagglutinin-specific memory B cell expansion by seasonal influenza virus infection reflects early-life imprinting and adaptation to the infecting virus. J Virol. 2019;93(8). doi:10.1128/JVI.00169-19
   PubMed Web of Science ®Google Scholar
• Koopmans M, de Jong MD. Avian influenza a H7N9 in Zhejiang, China. Lancet (London, England). 2013;381(9881):1882–83. doi:10.1016/S0140-6736(13)60936-8.
   PubMed Web of Science ®Google Scholar
• WHO. Monthly risk assessment summary. [accessed 2022 June 15]. https://www.who.int/teams/global-influenza-programme/avian-influenza/monthly-risk-assessment-summary
   Google Scholar
• Ma MJ, Wang XX, Wu MN, Wang XJ, Bao CJ, Zhang HJ, Yang Y, Xu K, Wang GL, Zhao M, et al. Characterization of antibody and memory T-cell response in H7N9 survivors: a cross-sectional analysis. Clin Microbiol Infect. 2020;26(2):247–54. doi:10.1016/j.cmi.2019.06.013.
   PubMed Web of Science ®Google Scholar
• Gou X, Wu X, Shi Y, Zhang K, Huang J. A systematic review and meta-analysis of cross-reactivity of antibodies induced by H7 influenza vaccine. Human Vaccines Immun. 2020;16(2):286–94. doi:10.1080/21645515.2019.1649551.
   PubMed Web of Science ®Google Scholar
• Xiang N, Bai T, Kang K, Yuan H, Zhou S, Ren R, Li X, Wu J, Deng L, Zeng G, et al. Sero-epidemiologic study of influenza A(H7N9) infection among exposed populations, China 2013-2014. Influenza Other Respi Viruses. 2017;11(2):170–76. doi:10.1111/irv.12435.
   PubMed Web of Science ®Google Scholar
• Kurosaki T, Kometani K, Ise W. Memory B cells. Nat Rev Immunol. 2015;15(3):149–59. doi:10.1038/nri3802.
   PubMed Web of Science ®Google Scholar
• Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, Zheng NY, Mays I, Garman L, Helms C, et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature. 2008;453(7195):667–71. doi:10.1038/nature06890.
   PubMed Web of Science ®Google Scholar
• Li GM, Chiu C, Wrammert J, McCausland M, Andrews SF, Zheng NY, Lee JH, Huang M, Qu X, Edupuganti S, et al. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc Natl Acad Sci U S A. 2012;109(23):9047–52. doi:10.1073/pnas.1118979109.
   PubMed Web of Science ®Google Scholar
• Krystal M, Elliott RM, Benz EW Jr, Young JF, Palese P. Evolution of influenza a and B viruses: conservation of structural features in the hemagglutinin genes. Proc Natl Acad Sci U S A. 1982;79(15):4800–04. doi:10.1073/pnas.79.15.4800.
   PubMed Web of Science ®Google Scholar
• Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, Throsby M, Goudsmit J, Wilson IA. Antibody recognition of a highly conserved influenza virus epitope. Sci. 2009;324(5924):246–51. doi:10.1126/science.1171491.
   PubMed Web of Science ®Google Scholar
• Asthagiri Arunkumar G, McMahon M, Pavot V, Aramouni M, Ioannou A, Lambe T, Gilbert S, Krammer F. Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice. Vaccine. 2019;37(37):5567–77. doi:10.1016/j.vaccine.2019.07.095.
   PubMed Web of Science ®Google Scholar
• Mesin L, Ersching J, Victora GD. Germinal center B cell dynamics. Immun. 2016;45(3):471–82. doi:10.1016/j.immuni.2016.09.001.
   Google Scholar
• McGuire HM, Vogelzang A, Warren J, Loetsch C, Natividad KD, Chan TD, Brink R, Batten M, King C. IL-21 and IL-4 collaborate to shape T-dependent antibody responses. J Immunol. 2015;195(11):5123–35. doi:10.4049/jimmunol.1501463.
   PubMed Web of Science ®Google Scholar
• Huang KY, Rijal P, Schimanski L, Powell TJ, Lin TY, McCauley JW, Daniels RS, Townsend AR. Focused antibody response to influenza linked to antigenic drift. J Clin Invest. 2015;125(7):2631–45. doi:10.1172/JCI81104.
   PubMed Web of Science ®Google Scholar
• Ekiert DC, Friesen RH, Bhabha G, Kwaks T, Jongeneelen M, Yu W, Ophorst C, Cox F, Korse HJ, Brandenburg B, et al. A highly conserved neutralizing epitope on group 2 influenza a viruses. Sci. 2011;333(6044):843–50. doi:10.1126/science.1204839.
   PubMed Web of Science ®Google Scholar
• Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, Jarrossay D, Vachieri SG, Pinna D, Minola A, Vanzetta F, et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza a hemagglutinins. Sci. 2011;333(6044):850–56. doi:10.1126/science.1205669.
   PubMed Web of Science ®Google Scholar
• Wang TT, Tan GS, Hai R, Pica N, Petersen E, Moran TM, Palese PM, Fouchier RA. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog. 2010;6(2):e1000796. doi:10.1371/journal.ppat.1000796.
   PubMed Web of Science ®Google Scholar
• Linderman SL, Hensley SE, Sant AJ. Antibodies with ‘original antigenic sin’ properties are valuable components of secondary immune responses to influenza viruses. PLoS Pathog. 2016;12(8):e1005806. doi:10.1371/journal.ppat.1005806.
   PubMed Web of Science ®Google Scholar